Macrophage activation syndrome in a child with juvenile idiopathic arthritis secondary to SARS-CoV-2
- Resource Type
- Authors
- Hacer Aktürk; Murat Tanyildiz; Emel Gonen; Aydın Celikyurt; Mehmet Taşdemir; Ilmay Bilge; Fatih Erbey
- Source
- Journal of Tropical Pediatrics
- Subject
- 2019-20 coronavirus outbreak
Macrophage Activation Syndrome (MAS)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
viruses
Arthritis
Case Report
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Interleukin 6
Rheumatology
Covid-19
Pandemic
juvenile idiopathic arthritis (JIA)
Medicine
Juvenile
Humans
Child
skin and connective tissue diseases
Pandemics
030304 developmental biology
Coronavirus
030203 arthritis & rheumatology
0303 health sciences
business.industry
SARS-CoV-2
Macrophage Activation Syndrome
fungi
Severe aute respiratory syndrome coronavirus-2 (SARS-Cov-2)
Macrophage activation syndrome (MAS)
Secondary haemophagocytic lymphohistocytosis (Shlh)
Juvenile idiopathic arthritis (JIA)
COVID-19
virus diseases
medicine.disease
Arthritis, Juvenile
body regions
Infectious Diseases
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Novel virus
Macrophage activation syndrome
Pediatrics, Perinatology and Child Health
Immunology
secondary haemophagocytic lymphohistocytosis (sHLH)
business
AcademicSubjects/MED00670
- Language
- English
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic affecting many countries and millions of people. Physicians have encountered some rare and challenging cases related to SARS-CoV-2, a novel virus with still many unknowns. In order to share our experience of a such clinical picture, we present here a child with SARS-CoV-2-induced macrophage activation syndrome in the setting of juvenile idiopathic arthritis.
NA